Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04306055
Other study ID # Blood donor recruitment
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 13, 2020
Est. completion date April 3, 2020

Study information

Verified date April 2020
Source Guangzhou Blood Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.


Description:

In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.

Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.

The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.


Recruitment information / eligibility

Status Completed
Enrollment 19491
Est. completion date April 3, 2020
Est. primary completion date March 13, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Blood donors whose last donation were between 1 Feb to 31 March, 2019.

Exclusion Criteria:

- Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire with precaution information
Ever blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.
Experimental: Questionnaire without precaution information
Ever blood donors in this group would receive a questionnaire which dose not include the information above.

Locations

Country Name City State
China Guangzhou Blood Center Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangzhou Blood Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differences of attitude about blood donation towards different questionnaires Compare participants' intention of blood donation after they read different information in the questionnaire. 1 day
Secondary Rates of blood donation during 3 weeks Blood donation rate of 3 groups will be followed 3 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05791968 - Blood Donation Could Improve Insulin Sensitivity N/A
Recruiting NCT02281565 - Attitudes About Blood Donation N/A
Enrolling by invitation NCT04410458 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) N/A
Active, not recruiting NCT01610635 - INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased N/A
Enrolling by invitation NCT04431180 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# N/A
Recruiting NCT04484896 - Message Framing on Recruiting Rh-D Negative Blood Donors N/A
Active, not recruiting NCT05678647 - Sucrosomial Iron and Iron Sulphate to Blood Donors N/A
Completed NCT05319951 - Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation N/A
Completed NCT05213130 - Blood Donation and Subjective Well-being N/A
Completed NCT00023023 - Study of Transfusion-Transmitted Infections
Recruiting NCT06101238 - BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy N/A
Enrolling by invitation NCT06138899 - Enhancing Blood Donation at Schools and Beyond in Malawi N/A
Completed NCT04370886 - Recruit Blood Donors Via SMS During Epidemic of COVID-19 N/A